BIO-FD&C Co.,Ltd.
Research BIO-FD&C Co.,Ltd. (251120.KQ) on Bullrun: market cap KRW 87.34B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker251120.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 87.34B
- Financial periodQ2 2026
- RevenueKRW 5.36B
- Net incomeKRW 1.97B
- Free cash flowKRW 1.78B
- Gross margin71.4%
Valuation Snapshot
latest market cap is KRW 87.34B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 87.34B | n/a | n/a | n/a |
Dividend history
About BIO-FD&C Co.,Ltd.
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BIO-FD&C Co.,Ltd.'s market cap?
BIO-FD&C Co.,Ltd.'s market capitalization is KRW 87.34B.
What does BIO-FD&C Co.,Ltd. do?
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.